Infectious Disease

We are also applying our APC Targeting Technology™ to the development of novel products for the treatment of a variety of infectious diseases. These include grant funded collaborations on HIV, anthrax and yersinia pestis (plague).

• CDX-2401 — Prevention and Treatment of AIDS
  Celldex is working with a team of researchers led by Rockefeller University immunologist Ralph M. Steinman, M.D., to develop a novel vaccine against HIV, the virus known to cause AIDS.
• CDX-2101 — Hepatitis B Therapeutic Vaccine Program
  We have an IND-ready clinical program for the therapeutic treatment of hepatitis B infection, a novel advance in the treatment of this difficult infectious disease.